Cyclin-dependent kinase 4/6 inhibitors restore the cell cycle by selectively inhibiting CDK 4 and 6 and blocking cell proliferation in a variety of tumor cells, including those of breast cancer [5]. Here, CDK4 is linked to breast cancer.